NCT04424316 A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. Status COMPLETED Phase PHASE3
NCT04424303 Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase N/A
NCT04413617 TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE Status COMPLETED Phase PHASE2
NCT04412252 Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy Status WITHDRAWN Phase PHASE2
NCT04410809 Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46 Status COMPLETED Phase PHASE1
NCT04408794 Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine Status COMPLETED Phase PHASE2/PHASE3
NCT04403776 PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation Status COMPLETED Phase PHASE1
NCT04399538 Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT04398732 Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients Status COMPLETED Phase N/A
NCT04398628 ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders Status RECRUITING Phase N/A
NCT04396639 Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients Status COMPLETED Phase PHASE4
NCT04396626 HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes Status TERMINATED Phase N/A
NCT04395950 Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism Status WITHDRAWN Phase PHASE1
NCT04394247 Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy Status COMPLETED Phase N/A
NCT04390776 Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules. Status COMPLETED Phase PHASE1
NCT04388878 Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04385290 Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC) Status RECRUITING Phase PHASE1/PHASE2
NCT04382326 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants Status COMPLETED Phase PHASE3